Cleared Traditional

K193346 - Codman Surgical Patties & Strips

K193346 is an FDA 510(k) clearance for Codman Surgical Patties & Strips, manufactured by Integra LifeSciences Corporation. The device is a Class 2 Neurology device with product code HBA cleared through the Traditional 510(k) pathway after a 353-day FDA review.

K193346 · Integra LifeSciences Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
353d
Days
Class 2
Risk

K193346 is an FDA 510(k) clearance for the Codman Surgical Patties & Strips. Classified as Neurosurgical Paddie (product code HBA), Class II - Special Controls.

Submitted by Integra LifeSciences Corporation (Mansfield, US). The FDA issued a Cleared decision on November 20, 2020 after a review of 353 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4700 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Integra LifeSciences Corporation devices

FDA 510(k) Submission Details - K193346

510(k) Number K193346 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2019
Decision Date November 20, 2020
Days to Decision 353 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
205d slower than avg
Panel avg: 148d · This submission: 353d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HBA Device Classification - Class 2, Special Controls

Product Code HBA Neurosurgical Paddie
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HBA Neurosurgical Paddie

All 11
Devices cleared under the same product code (HBA) and FDA review panel - the closest regulatory comparables to K193346.
MEDLINE NEURO SPONGE
K140369 · Medline Industries, Inc. · Sep 2014
AMERICAN SURGICAL COMPANY/ NEUROSURGICAL SPONGES (BRAND)
K112598 · American Surgical Company, LLC · Jun 2013
DELICOT
K121822 · American Surgical Company, LLC · Sep 2012
AESCULAP NEURO PATTIES
K062406 · Aesculap, Inc. · Sep 2006
PACIFIC SURGICAL PATTIES
K993019 · V. Mueller Neuro/Spine · Mar 2000
ULTRACELL NEURO SPONGES
K973083 · Ultracell Medical Technologies, Inc. · Dec 1997